Virtus LifeSci Biotech Products ETF
19 hedge funds and large institutions have $11.9M invested in Virtus LifeSci Biotech Products ETF in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
9% less capital invested
Capital invested by funds: $13.1M → $11.9M (-$1.2M)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$429K | |
| 2 | +$288K | |
| 3 | +$124K | |
| 4 |
SMG
Smart Money Group
Eastland,
Texas
|
+$74.8K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$63.7K |
Top Sellers
| 1 | -$1.16M | |
| 2 | -$1.02M | |
| 3 | -$119K | |
| 4 |
CA
Calton & Associates
Tampa,
Florida
|
-$91K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$22.8K |